These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8008433

  • 21. Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres.
    Li X, Dai J, Tang Y, Li L, Jin G.
    Mar Drugs; 2017 Jan 18; 15(1):. PubMed ID: 28106765
    [Abstract] [Full Text] [Related]

  • 22. Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro.
    Morimoto M, Mori H, Otake T, Ueba N, Kunita N, Niwa M, Murakami T, Iwanaga S.
    Chemotherapy; 1991 Jan 18; 37(3):206-11. PubMed ID: 1889308
    [Abstract] [Full Text] [Related]

  • 23. Restricted distribution of Streptococcus milleri carbohydrate type antigens amongst other viridans streptococci.
    Inoue M, Matsunoshita N, Yakushiji T.
    J Med Microbiol; 1992 Sep 18; 37(3):211-3. PubMed ID: 1518038
    [Abstract] [Full Text] [Related]

  • 24. Interactions of an antimicrobial peptide, tachyplesin I, with lipid membranes.
    Matsuzaki K, Fukui M, Fujii N, Miyajima K.
    Biochim Biophys Acta; 1991 Nov 18; 1070(1):259-64. PubMed ID: 1751532
    [Abstract] [Full Text] [Related]

  • 25. Effects of tachyplesin I on human U251 glioma stem cells.
    Ding H, Jin G, Zhang L, Dai J, Dang J, Han Y.
    Mol Med Rep; 2015 Apr 18; 11(4):2953-8. PubMed ID: 25434611
    [Abstract] [Full Text] [Related]

  • 26. Viridans streptococci in infective endocarditis: species distribution and susceptibility to antibiotics.
    Horaud T, Delbos F.
    Eur Heart J; 1984 Oct 18; 5 Suppl C():39-44. PubMed ID: 6519085
    [Abstract] [Full Text] [Related]

  • 27. [Bacteria-selective synergism between the antimicrobial peptides magainin 2 and tachyplesin I: toward cocktail therapy].
    Kobayashi S.
    Yakugaku Zasshi; 2002 Nov 18; 122(11):967-73. PubMed ID: 12440153
    [Abstract] [Full Text] [Related]

  • 28. Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci.
    da Silva BR, de Freitas VA, Carneiro VA, Arruda FV, Lorenzón EN, de Aguiar AS, Cilli EM, Cavada BS, Teixeira EH.
    Peptides; 2013 Apr 18; 42():78-83. PubMed ID: 23340019
    [Abstract] [Full Text] [Related]

  • 29. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds.
    Rao AG.
    Arch Biochem Biophys; 1999 Jan 01; 361(1):127-34. PubMed ID: 9882437
    [Abstract] [Full Text] [Related]

  • 30. Synergistic inhibitory effect of cationic peptides and antimicrobial agents on the growth of oral streptococci.
    Kim SS, Kim S, Kim E, Hyun B, Kim KK, Lee BJ.
    Caries Res; 2003 Jan 01; 37(6):425-30. PubMed ID: 14571120
    [Abstract] [Full Text] [Related]

  • 31. Action mechanism of tachyplesin I and effects of PEGylation.
    Imura Y, Nishida M, Ogawa Y, Takakura Y, Matsuzaki K.
    Biochim Biophys Acta; 2007 May 01; 1768(5):1160-9. PubMed ID: 17320042
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O, Ghiselli R, Silvestri C, Kamysz W, Orlando F, Mocchegiani F, Di Matteo F, Riva A, Lukasiak J, Scalise G, Saba V, Giacometti A.
    Antimicrob Agents Chemother; 2007 Jun 01; 51(6):2005-10. PubMed ID: 17403995
    [Abstract] [Full Text] [Related]

  • 33. Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells.
    Ouyang GL, Li QF, Peng XX, Liu QR, Hong SG.
    World J Gastroenterol; 2002 Dec 01; 8(6):1053-8. PubMed ID: 12439924
    [Abstract] [Full Text] [Related]

  • 34. In Vitro Study of Antitumor Effect of Antimicrobial Peptide Tachyplesin I in Combination with Cisplatin.
    Kuzmin DV, Emel'yanova AA, Kalashnikova MB, Panteleev PV, Ovchinnikova TV.
    Bull Exp Biol Med; 2018 Jun 01; 165(2):220-224. PubMed ID: 29922995
    [Abstract] [Full Text] [Related]

  • 35. Bacteria-selective synergism between the antimicrobial peptides alpha-helical magainin 2 and cyclic beta-sheet tachyplesin I: toward cocktail therapy.
    Kobayashi S, Hirakura Y, Matsuzaki K.
    Biochemistry; 2001 Dec 04; 40(48):14330-5. PubMed ID: 11724544
    [Abstract] [Full Text] [Related]

  • 36. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
    Rodríguez-Avial C, García MM, Rodríguez-Avial I, Picazo JJ.
    Rev Esp Quimioter; 1999 Dec 04; 12(4):346-51. PubMed ID: 10855014
    [Abstract] [Full Text] [Related]

  • 37. Antimicrobial tachyplesin peptide precursor. cDNA cloning and cellular localization in the horseshoe crab (Tachypleus tridentatus).
    Shigenaga T, Muta T, Toh Y, Tokunaga F, Iwanaga S.
    J Biol Chem; 1990 Dec 05; 265(34):21350-4. PubMed ID: 2250028
    [Abstract] [Full Text] [Related]

  • 38. Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.
    Edwards IA, Elliott AG, Kavanagh AM, Blaskovich MAT, Cooper MA.
    ACS Infect Dis; 2017 Dec 08; 3(12):917-926. PubMed ID: 28960954
    [Abstract] [Full Text] [Related]

  • 39. Eukaryotic expression and antimicrobial spectrum determination of the peptide tachyplesin II.
    Xu F, Meng K, Wang YR, Luo HY, Yang PL, Wu NF, Fan YL, Yao B.
    Protein Expr Purif; 2008 Apr 08; 58(2):175-83. PubMed ID: 18249136
    [Abstract] [Full Text] [Related]

  • 40. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
    Ramamoorthy A, Thennarasu S, Tan A, Gottipati K, Sreekumar S, Heyl DL, An FY, Shelburne CE.
    Biochemistry; 2006 May 23; 45(20):6529-40. PubMed ID: 16700563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.